Results for tag: "Ventavis"

Ventavis is a drug used to treat pulmonary arterial hypertension (PAH), a type of cardiovascular disease. It is a vasodilator, meaning it relaxes and widens the blood vessels, allowing for improved blood flow and reduced pressure in the pulmonary arteries. Ventavis is administered through inhalation, and is available in both capsule and solution form. It is typically prescribed in combination with other drugs to treat PAH. Ventavis is a relatively new drug, having been approved by the U.S. Food and Drug Administration in 2004. It is currently marketed by Actelion Pharmaceuticals, a subsidiary of Johnson & Johnson. Other companies involved in the Ventavis market include GlaxoSmithKline, Pfizer, and Bayer. Show Less Read more